Nokia Oyj
14.8.2026 14:30:00 CEST | Globenewswire | Press release
Nokia Corporation - Managers' transactions (Prosi)
Nokia Corporation - Managers' transactions (Prosi)
Nokia Corporation
Managers’ transactions
14 August 2026 at 15:30 EEST
Nokia Corporation - Managers' transactions (Prosi)
Transaction notification under Article 19 of EU Market Abuse Regulation.
____________________________________________
Person subject to the notification requirement
Name: Prosi, Stephan
Position: Other senior manager
Issuer: Nokia Corporation
LEI: 549300A0JPRWG1KI7U06
Notification type: INITIAL NOTIFICATION
Reference number: 169622/4/4
___________________________________________
Transaction date: 2026-08-13
Venue: XHEL
Instrument type: SHARE
ISIN: FI0009000681
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 251 Unit price: 9.0910 EUR
Aggregated transactions
(1): Volume: 251 Volume weighted average price: 9.0910 EUR
____________________________________________
About Nokia
Nokia is a global leader in connectivity for the AI era. With expertise across fixed, mobile, and transport networks, we’re advancing connectivity to secure a brighter world.
Inquiries:
Nokia Communications
Phone: +358 10 448 4900
Email: press.services@nokia.com
Maria Vaismaa, Vice President, Corporate Communications
Nokia
Investor Relations
Phone: +358 931 580 507
Email: investor.relations@nokia.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chemometec A/S16.9.2026 14:22:33 CEST | Press release
Notice of Annual General Meeting 2026
Elemica16.9.2026 14:00:00 CEST | Press release
Elemica® Named a Leader in the 2026 Nucleus Research Control Tower Technology Value Matrix
Apogee Minerals Ltd.16.9.2026 14:00:00 CEST | Press release
Apogee Minerals Closes Knife Lake Copper Project Option Transaction and Files Independent NI 43-101 Technical Report
Novo Nordisk A/S16.9.2026 14:00:00 CEST | Press release
Novo and Anthropic will collaborate to advance drug discovery with Claude
Teva Pharmaceutical Industries Ltd16.9.2026 14:00:00 CEST | Press release
Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom